Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

December 18, 2024

Renamed

Ergometrine renamed to Ergonovine.

Reassessed

Category:17th-century pharmacists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:19th-century pharmacists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:20th-century pharmacists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:21st-century pharmacists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Template:ATC category (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code A (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code B (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code D (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code G (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code H (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code I (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code J (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code L (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code M (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code P (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code S (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC code V (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Category:ATC code templates (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Template:ATC codes lead (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATC codes short (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:ATCvet (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Actiq (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Acunol (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Adrenergic receptor modulators (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Aetiotropic (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Amosan (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Anesthetic vaporizer (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Anticonvulsants (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:Antidepressants (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Antifungals for dermatologic use (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Antimalarial agents (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Antipsoriatics (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Antiseptics (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Antra (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Benzedrine in popular culture (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Biotechnology (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Chocolate (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Cobalamin (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Controlled substances in Oregon (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Cytomel (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:DNA antivirals (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Discovery and development of dual serotonin and norepinephrine reuptake inhibitors (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Diuretics (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:Dopamine receptor modulators (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Drug harmfulness (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Drug policy (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Template:Drug use (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Category:Drugs by target organ system (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Drugs controlled by the UK Misuse of Drugs Act (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Drugs not assigned an ATC code (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Echinopsis scopulicola (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Ecstasy (drug) (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Eczemol (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Emsam (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Endocannabinoid reuptake inhibitors (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Enkephalinase inhibitors (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Etonogestrel birth control implant (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Etozoline (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Films about drugs (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Gonadotropin-releasing hormone analogue (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Hallucinogens (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Heartgard (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Heat rub (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Hydrolases (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Template:IUPHAR chapter (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
IcyHot (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
WP:Identifying reliable sources (medicine) (talk) reassessed. Quality rating changed from Project-Class to NA-Class. (rev · t)
Template:Intracellular chemotherapeutic agents (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Levomethadyl acetate (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
WP:Manual of Style/Medicine-related articles (talk) reassessed. Quality rating changed from Project-Class to NA-Class. (rev · t)
Template:Medical imaging (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Category:Medicinal herbs and fungi (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Medicinal plants (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Methylenedioxymethoxyamphetamine (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Michael D. Horowitz (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Monoclonals for tumors (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Category:Novartis (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Opioids (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Template:Oral hypoglycemics and insulin analogs (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Category:Oxazolidinone antibiotics (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmaceutical companies of Finland (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmaceutical companies of Sweden (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Pharmaceutical form (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Pharmacies of Norway (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmacies of the United States (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Pharmacogenetics (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Pharmacology stubs (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Population pharmacokinetics (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Premarin (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Psorizide Forte (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Racemic epinephrine (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
WP:Requested articles/Medicine/Pharmacology (talk) reassessed. Quality rating changed from Project-Class to NA-Class. (rev · t)
Serratio peptidase (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Sodium valproate (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Sundown: The Future of Children and Drugs (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Sunscreening agents (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Category:Swedish pharmacologists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Syrian pharmacologists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Template:Targeted cancer therapeutic agents (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Tepezcohuite (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Teratogens (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
TobraDex (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Transporter reversal (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Trifluoroperazine (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Unknown-importance pharmacology articles (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Template:Vaccines (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Valproate semisodium (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
WP:Version 1.0 Editorial Team/Pharmacology articles by quality log (talk) reassessed. Quality rating changed from Project-Class to NA-Class. (rev · t)
Virtual high throughput screening (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Vitamin R (talk) reassessed. Quality rating changed from Disambig-Class to NA-Class. (rev · t)
WP:WikiProject Pharmacology (talk) reassessed. Quality rating changed from Project-Class to NA-Class. (rev · t)
WP:WikiProject Pharmacology/Categorization (talk) reassessed. Quality rating changed from Project-Class to NA-Class. (rev · t)
Xantinol nicotinate (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)

Assessed

Cosibelimab (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Ergonovine (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Draft:NNC2215 (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
RO5203648 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

Removed

File:Fumeida.jpg (talk) removed.

December 17, 2024

Reassessed

(R)-1-Aminoindan (talk) reassessed. Quality rating changed from C-Class to Redirect-Class. (rev · t) Importance rating changed from Unknown-Class to NA-Class. (rev · t)
ATC code (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Acne-treating agents (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:Adrenergic antagonist (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Agents acting on the renin–angiotensin system (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Template:Agents against leishmaniasis and trypanosomiasis (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Analgesics (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Beta-hydroxy beta-methylbutyric acid (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:CRF-1 antagonists (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Chlorhexidine gluconate (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Chloroquine (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Category:Cholecystokinin (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Cholecystokinin antagonists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Crinecerfont (talk) reassessed. Importance rating changed from Low-Class to Mid-Class. (rev · t)
Category:Drugs (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Template:Drugs for treatment of hyperkalemia and hyperphosphatemia (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Category:Entheogens (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Evofosfamide (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Gutka (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
HIV vaccine development (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Hormonal breast enhancement (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Template:Infobox drug (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
Category:NK2 receptor antagonists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:NK3 receptor antagonists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Nootropics (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:Opioids (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Pharmaceutical companies (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmaceutical companies of the United Kingdom (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmaceutical companies of the United States (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmacies (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmacodynamics (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmacokinetics (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmacologists (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmacology (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Pharmacy (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Category:Psychoactive drugs (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Robitussin DAC (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Serotonergic (talk) reassessed. Quality rating changed from Disambig-Class to NA-Class. (rev · t)
Spottle (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Category:Tobacco (talk) reassessed. Quality rating changed from Category-Class to NA-Class. (rev · t)
Vasodilator (talk) reassessed. Quality rating changed from Redirect-Class to NA-Class. (rev · t)
Template:WikiProject Pharmacology (talk) reassessed. Quality rating changed from Template-Class to NA-Class. (rev · t)
WP:WikiProject Pharmacology/Classification (talk) reassessed. Quality rating changed from Project-Class to NA-Class. (rev · t)

Assessed

File:Fumeida.jpg (talk) assessed. Quality assessed as File-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Potassium asparaginate (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Potassium aspartate (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Draft:Psychedelic Medicine (talk) assessed. Quality assessed as NA-Class. (rev · t)
Sipavibart (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Zapomeran (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)

December 15, 2024

Reassessed

Acoltremon (talk) reassessed. Quality rating changed from NA-Class to Stub-Class. (rev · t)
Adaptive design (medicine) (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Amikacin (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Atracurium besilate (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Baricitinib (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
C15H16O5 (talk) reassessed. Quality rating changed from Stub-Class to List-Class. (rev · t)
Ceftriaxone (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Contrast-enhanced ultrasound (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Cyclophosphamide (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Isoniazid (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
McKesson Corporation (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Omzotirome (talk) reassessed. Quality rating changed from NA-Class to Stub-Class. (rev · t)
Pyrimethamine (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Sodium nitroprusside (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)

Assessed

Anidoxime (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Mean kinetic temperature (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Category:Species that are or were threatened by human consumption for medicinal or magical purposes (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)

Removed

Category:Species endangered by human consumption for medicinal or magical purposes (talk) removed.

December 14, 2024

Reassessed

Aminoquinoline (talk) reassessed. Importance rating changed from Unknown-Class to Low-Class. (rev · t)
RDS03-94 (talk) reassessed. Importance rating changed from Unknown-Class to Low-Class. (rev · t)

Assessed

Garadacimab (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
Hydrophilization (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
ID-4708 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

December 13, 2024

Renamed

N-Acetyl-γ-aminobutyraldehyde renamed to 4-Acetamidobutanal.

Reassessed

Adverse drug reaction (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Cannabinoid receptor (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Fluorouracil (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Ketanserin (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Oxytocinase (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Paliperidone (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Phenelzine (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
SoRI-20041 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Streptomycin (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Verapamil (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Γ-Hydroxybutyraldehyde (talk) reassessed. Quality rating changed from NA-Class to Start-Class. (rev · t)

Assessed

4-Acetamidobutanal (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
File:Jelly Ear, Auricularia auricula-judae, UK 2.jpg (talk) assessed. Importance assessed as NA-Class. (rev · t)
Prostaglandin antagonist (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

Removed

Draft:Centrient Pharmaceuticals (talk) removed.

December 12, 2024

Reassessed

6-Hydroxymelatonin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
ARO-HSD (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
Aravofloxacin (talk) reassessed. Quality rating changed from NA-Class to Stub-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
Clofazimine (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Dichloroacetic acid (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Extended cycle combined hormonal contraceptive (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
FK1012 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Gemcitabine (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Hexane (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Hydrocodone/paracetamol (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Hydroxocobalamin (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Levamisole (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Nilotinib (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Pentobarbital (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Pilocarpine (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Prolotherapy (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Ranbaxy Laboratories (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Saccharomyces boulardii (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Spermicide (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Suramin (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)

Assessed

ASC41 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
AZD-1134 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
TNIK (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)